27.08.18: Not intended for U.S. and UK Media

Bayer submits European marketing authorization application for larotrectinib for the treatment of TRK fusion cancermehr ...
Source: Bayer IR Newsfeed: Events - Category: Pharmaceuticals Source Type: news